The GLP-1 mechanism, in plain English
Semaglutide is a GLP-1 receptor agonist: a medication that mimics a hormone your gut already makes after you eat. Understanding what that hormone actually does explains almost everything about how the medication feels, why it works, and why the side effects show up where they do.
Educational content only — not medical advice. All prescribing decisions are made by a U.S. licensed clinician after intake.
When food reaches your small intestine, cells there release glucagon-like peptide-1 (GLP-1). It travels to the pancreas, the stomach, and the brain, and delivers one broad message: food has arrived, you can stop eating soon.
Natural GLP-1 breaks down within minutes. Semaglutide is engineered to resist that breakdown, so a single weekly dose keeps the signal running continuously instead of in short bursts after meals.
The mechanism isn't one effect — it's three, working together.
Nearly all early side effects — nausea, fullness, constipation, fatigue — come from how quickly your gut adapts to slower emptying. Starting at a low dose and increasing every few weeks gives your body time to adjust.
Some people do best staying at a lower dose long-term. More medication is not automatically more result; the goal is the lowest dose that produces steady progress with tolerable side effects.
Appetite change usually shows up in the first one to two weeks, well before the scale moves. Weight change tends to be gradual and non-linear: some weeks nothing, then a step down.
Clinical trials of semaglutide for weight management have shown average total body weight reductions in the low-to-mid teens as a percentage over roughly a year, with wide individual variation. Results depend heavily on protein intake, resistance training, and sleep.
It doesn't preserve muscle for you — that's protein and strength training. It doesn't correct thyroid dysfunction, poor sleep, or untreated depression, all of which stall progress. And it doesn't permanently reset appetite: when people stop, appetite generally returns, which is why a maintenance plan matters more than the starting dose.
Most people notice reduced appetite within the first one to two weeks. Meaningful weight change usually becomes visible between weeks four and twelve as the dose steps up.
Semaglutide is the active ingredient; Ozempic and Wegovy are brand-name products containing it, approved for different uses and dosed differently. Compounded semaglutide is prepared by a licensed compounding facility and is not an FDA-approved finished product.
Nausea, fullness, constipation, and occasional reflux — most common in the first weeks and after each dose increase. Smaller meals, more water, and adequate fibre usually help. Report severe or persistent symptoms to your clinician.
No, but appetite generally returns after stopping. Many people step down to a maintenance dose rather than stopping abruptly, alongside habits that hold the result.
Yes, and you should try to. Adequate protein and two to three resistance sessions a week are the main defence against losing lean mass during weight loss.
Take the free 3-minute quiz and a licensed clinician reviews whether a GLP-1 protocol is appropriate for you.
A week-by-week walkthrough
What peptides are, what they do, and what to ignore
A step-by-step guide to getting a semaglutide prescription
How peptides work, what they treat, and what to expect
